AKT1 and prostate carcinoma: Results here would confirm recent evidence suggesting that PPARγ is generally associated with a poor prognosis in prostate cancer [55], since it is related to an increase in AKT expression and further mitogenesis [56] or other AR-dependent and independent mechanisms [57].